Australia markets closed

Virios Therapeutics, Inc. (VIRI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4695+0.0076 (+1.65%)
At close: 04:00PM EDT
0.4509 -0.02 (-3.96%)
After hours: 06:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
9,716
1,728
8,070
10,796
194.013
Selling general and administrative
4,697
3,719
4,246
4,845
9,811
Total operating expenses
14,413
5,447
12,315
15,641
10,005
Operating income or loss
-14,413
-5,447
-12,315
-15,641
-10,005
Interest expense
-
-
-
-
384.222
Total other income/expenses net
-
-
-
-325
43.221
Income before tax
-14,715
-5,296
-12,248
-15,960
-10,346
Income tax expense
0
0
0
0
0
Income from continuing operations
-14,715
-5,296
-12,248
-15,960
-10,346
Net income
-14,715
-5,296
-12,248
-15,960
-10,346
Net income available to common shareholders
-14,715
-5,296
-12,248
-15,960
-10,346
Basic EPS
-1.11
-0.28
-1.11
-1.92
-2.10
Diluted EPS
-1.11
-0.28
-1.11
-1.92
-2.10
Basic average shares
11,070
18,777
11,070
8,329
4,927
Diluted average shares
11,070
18,777
11,070
8,329
4,927